Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en SciELO
Similares en Google
Compartir
Archivos Españoles de Urología (Ed. impresa)
versión impresa ISSN 0004-0614
Resumen
GONZALO RODRIGUEZ, Victoria et al. The use of NMP22 Bladder-Chek for the diagnosis and folow-up of bladder cancer. Arch. Esp. Urol. [online]. 2008, vol.61, n.3, pp.377-384. ISSN 0004-0614.
Objectives: The goal of this work is to evaluate the usefulness of NMP22 BladderChek in the diagnosis and follow-up of bladder cancer, comparing it with cystoscopy and urine cytology. Methods: Group 1: 109 asymptomatic patients on follow up for bladder cancer underwent cystoscopy, cytology and NMP22 BladderChek. Group 2: 15 patients with history of hematuria underwent cystoscopy and NMP22 BladderChek. Results: Group 1: 9 patients had tumor relapse. Sensitivity was 25% for NMP22 test, 50% for citology and 100% for cystoscopy. Specificity was 91.1%, 94.1% and 95% respectively. Group 2: 12 patients had bladder cancer. The sensitivity was of 83.3% for NMP22 BladderChek and 100% for cystoscopy. The specificity was of 100% for NMP22 BladderChek and 66.7% for cystoscopy. Conclusions: The low sensitivity of NMP22 Bladder-Chek invalidates it as alternative method to cystoscopy in the follow-up of bladder cancer. But it can be recommended for screening in patients without history of bladder cancer but with an increased risk (smokers, patients with dysuria and hematuria).
Palabras clave : Bladder Cancer; NMP22 BladderChek; Cystoscopy; Citology.